Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share

v3.21.2
Earnings Per Share
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic earnings per share is calculated using the weighted average number of shares of the Company’s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company’s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants.
As of September 30, 2021 and December 31, 2020, APC held 10,925,702 and 12,323,164 shares of ApolloMed’s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share.
Below is a summary of the earnings per share computations:
Three Months Ended September 30, 2021 2020
Earnings per share – basic
$ 0.77  $ 0.46 
Earnings per share – diluted
$ 0.74  $ 0.45 
Weighted average shares of common stock outstanding – basic
44,301,060  36,364,839 
Weighted average shares of common stock outstanding – diluted
46,273,640  37,551,740 
Nine Months Ended September 30, 2021 2020
Earnings per share – basic $ 1.38  $ 0.77 
Earnings per share – diluted $ 1.33  $ 0.75 
Weighted average shares of common stock outstanding – basic 43,608,116  36,149,692 
Weighted average shares of common stock outstanding – diluted 45,339,372  37,249,967 

Below is a summary of the shares included in the diluted earnings per share computations:
Three Months Ended September 30, 2021 2020
Weighted average shares of common stock outstanding – basic 44,301,060  36,364,839 
Stock options 583,639  187,843 
Warrants 1,083,216  960,806 
Restricted stock awards 305,725  38,252 
Weighted average shares of common stock outstanding – diluted 46,273,640  37,551,740 
Nine Months Ended September 30, 2021 2020
Weighted average shares of common stock outstanding – basic 43,608,116  36,149,692 
Stock options 498,296  178,445 
Warrants 971,935  890,489 
Restricted stock awards 261,025  31,341 
Weighted average shares of common stock outstanding – diluted 45,339,372  37,249,967